European Business Summits
info@ebsummit.eu – 0032 (0) 2 645 34 80
TRANSPARENCY REGISTER 268958411031-65
PRIVACY-POLICY | GENERAL TERMS OF SALES

Director General DG SANTE
Member of the European Parliament
Member of the European Parliament
Member of the European Parliament
CEO Cancer Patients Europe
President of International Patient Organization for Primary Immunodeficiencies (IPOPI)
Associate Professor of International Health Policy at London School of Economics (LSE)
Associate Director at European Policy Centre
Head of Division at the Centre for European Policy
Head of Commercial Operations EMEA for the Pharmaceuticals Division and ExCo Member at Bayer AG
Director of EU Public Affairs and Advocacy of the Alliance for Regenerative Medicine (ARM)
Executive Director International Corporate Affairs, Alzheimer’s disease, Eli Lilly and Company
Group Leader and Head of Facility at Humanitas Research Hospital
Senior Director EU Policy Strategy at CSL Behring
Euronews, Euractiv, CNBC Presenter
EU Health Journalist
10 MAY 2023
Closed meeting
The revision of the EU’s Pharma Strategy offers a once in a generation opportunity to highlight to current shortcomings and opportunities in EU health policy when it comes to rare and non-communicable diseases (cardiovascular disease, diabetes etc.). Given the nature of public-private partnerships in the healthcare landscape, listening to the voices of industry is a key factor when it comes to fostering innovation and translating this into improved patient outcomes.
MAY 2023
Closed meeting
AI offers unprecedented opportunities for healthcare, such as reduced costs, increased automation and rapid data processing. On the other hand, questions of data privacy, bias and vulnerabilities may also increase health inequalities. As the EU moves towards the implementation of the EHDS, engaging with stakeholders and ensuring that opportunities can be properly harnessed will be essential for its success.
SEPTEMBER 2023
Closed meeting
As the EU struggles to attract and maintain R&D and investments in the healthcare sector coupled with strategic vulnerabilities in supply chains, the need to develop home-grown and innovative treatments has never been more apparent. Reducing IP and regulatory hurdles in the EU, along with incentivizing investment, infrastructure and skills will be vital to cultivate a competitive healthcare ecosystem.
8 JUNE 2023
European Business Summits
info@ebsummit.eu – 0032 (0) 2 645 34 80
TRANSPARENCY REGISTER 268958411031-65
PRIVACY-POLICY | GENERAL TERMS OF SALES
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.